The data from this study suggest that in refractory AML cells, depletion of PTEN and the unopposed hyperactivity of AKT result in the upregulation of glycolysis and subsequently confer resistance to chemotherapy102. This evidence concerns the gene AKT1 and acute myeloid leukemia.